Viewing StudyNCT00003138



Ignite Creation Date: 2024-05-05 @ 10:00 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00003138
Status: COMPLETED
Last Update Posted: 2023-06-29
First Post: 1999-11-01

Brief Title: Erythropoietin EPO- Filgrastim G-CSF vs Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Sponsor: Eastern Cooperative Oncology Group
Organization: Eastern Cooperative Oncology Group

Conditions & Keywords Data

Conditions:
Name
Anemia
Myelodysplastic Syndromes
Keywords:
Name View
filgrastim View
anemia View
refractory anemia View
myelodysplastic syndromes View
erythropoietin View